siRNA / miRNA gene silencing Human A498

- Found 5127 results

Site-directed mutagenesis (SDM) can be challenging, particularly during detection/confirmation of (SDM) in colonies by sequencing or PCR techniques. This common issue in SDM is heavily relying on designing of mutagenic primer pairs. The best solution is to design the mutagenic primers that have extended 3'-ends/3'-overhang. This would provide the annealing region between the mutagenic primer pair is essentially shorter. and hence ensure a lower annealing temperature for the primer pair along with a higher chance of annealing to the template.

DNA Site Directed Mutagenesis (SDM) Human Point mutation LNCaP Androgen Receptor splice variant (AR-V)

Get tips on using miRNeasy FFPE Kit to perform RNA isolation / purification Tissue - Human Kidney

Products Qiagen miRNeasy FFPE Kit

Get tips on using miRNeasy Mini kit to perform RNA isolation / purification Tissue - Human Liver

Products Qiagen miRNeasy Mini kit

Get tips on using miRNeasy Mini kit to perform RNA isolation / purification Tissue - Human Veins

Products Qiagen miRNeasy Mini kit

Get tips on using miRNeasy FFPE Kit to perform RNA isolation / purification Tissue - Human Tonsil

Products Qiagen miRNeasy FFPE Kit

Get tips on using miRNeasy FFPE Kit to perform RNA isolation / purification Tissue - Human Prostate

Products Qiagen miRNeasy FFPE Kit

Get tips on using miRNeasy Mini kit to perform RNA isolation / purification Tissue - Human Muscles

Products Qiagen miRNeasy Mini kit

Get tips on using miRNeasy FFPE Kit to perform RNA isolation / purification Tissue - Human Liver

Products Qiagen miRNeasy FFPE Kit

Get tips on using miRNeasy Mini kit to perform RNA isolation / purification Tissue - Human Larynx

Products Qiagen miRNeasy Mini kit

Get tips on using miRNeasy FFPE Kit to perform RNA isolation / purification Tissue - Human Colon

Products Qiagen miRNeasy FFPE Kit

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms